Growing community of inventors

Sohag, Egypt

Mohammad Mahboob Alam

Average Co-Inventor Count = 6.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Mohammad Mahboob AlamHany Mohamed Abd El-Lateef Ahmed (7 patents)Mohammad Mahboob AlamMai Mostafa Khalaf Ali (7 patents)Mohammad Mahboob AlamAntar Ahmed Abdelhamid Ahmed (7 patents)Mohammad Mahboob AlamAmer A Amer (7 patents)Mohammad Mahboob AlamSahar M Mohamed (7 patents)Mohammad Mahboob AlamMohammad Mahboob Alam (7 patents)Hany Mohamed Abd El-Lateef AhmedHany Mohamed Abd El-Lateef Ahmed (362 patents)Mai Mostafa Khalaf AliMai Mostafa Khalaf Ali (337 patents)Antar Ahmed Abdelhamid AhmedAntar Ahmed Abdelhamid Ahmed (282 patents)Amer A AmerAmer A Amer (169 patents)Sahar M MohamedSahar M Mohamed (7 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. King Fahd University of Petroleum and Minerals (7 from 3,222 patents)


7 patents:

1. 12180172 - [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound

2. 12006288 - 3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound

3. 11981646 - 3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound

4. 11981647 - 3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound

5. 11970471 - 3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl }- 1,2,4-oxadiazole as an antitumor and antimicrobial compound

6. 11905261 - 3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound

7. 11884637 - 3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/17/2025
Loading…